ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility

Cited by (240)

Items 101–200 of 240

1. ATM in breast and brain tumors: a comprehensive review
   Asghari Estiar Mehrdad, Parvin Mehdipour · 2018 · Cancer Biology and Medicine
2. ATM gene alterations in childhood acute lymphoblastic leukemias
   Fabienne Gumy‐Pause, Pierre Wacker, Philippe Maillet, David R. Betts, André‐Pascal Sappino · 2003 · Human Mutation
3. TP53, BRCA1, and BRCA2 Tumor Suppressor Genes Are Not Commonly Mutated in Survivors of Hodgkin’s Disease With Second Primary Neoplasms
   Kim E. Nichols, John A. Heath, Debra Friedman, Jaclyn A. Biegel, Arupa A. Ganguly, Peter Mauch, Lisa Diller · 2003 · Journal of Clinical Oncology
4. Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
   Angela Toss, Elena Tenedini, Claudia Piombino, Marta Venturelli, Isabella Marchi, Elisa Gasparini, Elena Barbieri, Elisabetta Razzaboni, Federica Domati, Federica Caggia et al. · 2021 · Genes
5. The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis
   Linbo Gao, Xin-Min Pan, Hong Sun, Xia Wang, Li Rao, Li-Juan Li, Weibo Liang, Meili Lv, Wenzhong Yang, Lin Zhang · 2010 · Journal of Experimental & Clinical Cancer Research
6. Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease
   Masatoshi Takagi · 2003 · Blood
7. The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia
   Muzaffer Dükel, William S. Streitfeld, Tsz Ching Chloe Tang, Lindsey R. F. Backman, Lingbao Ai, W. Stratford May, Kevin D. Brown · 2016 · Journal of Biological Chemistry
8. Detection ofATMGene Mutation in Human Glioma Cell Line M059J by a Rapid Frameshift/Stop Codon Assay in Yeast
   Rika Tsuchida, Takayuki Yamada, Masatoshi Takagi, Akira Shimada, Chikashi Ishioka, Yoko Katsuki, Takashi Igarashi, Luciana Chessa, Domenico Delia, Hirobumi Teraoka et al. · 2002 · Radiation Research
9. An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China
   Na Wang, Xiujuan Dong, Rong‐Miao Zhou, Wei Guo, Xiaojuan Zhang, Yan Li · 2007 · Molecular Biology Reports
10. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
    Geoffrey Yuyat Ku, Yelena M. Kemel, Steven Brad Maron, Joanne F. Chou, Vignesh Ravichandran, Zarina Shameer, Anna Maio, Elizabeth S. Won, David Paul Kelsen, David H. Ilson et al. · 2021 · JAMA Network Open
11. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer
    Katri Pylkäs, Johanna Tommiska, Kirsi Syrjäkoski, Juha Kere, Magtouf Hnaidi Gatei, Nicola Waddell, Minna Allinen, Sanna‐Maria Karppinen, Katrin Rapakko, Helena A. Kääriäinen et al. · 2006 · Carcinogenesis
12. ATM haplotypes and breast cancer risk in Jewish high-risk women
    M Koren, Gad Kimmel, Edna Ben‐Asher, I. G Gal, Moshe Zvi Papa, Jacques Samuel Beckmann, Doron Lancet, Ron Shamir A, Eitan Friedman · 2006 · British Journal of Cancer
13. Constitutional alterations of the ATM gene in early onset sporadic breast cancer: Table 1
    Philippe Maillet, Herve R. Bonnefoi, G Vaudan-Vutskits, B Pajk, T Cufer, William David Foulkes, Pierre Olivier Chappuis, A-P Sappino · 2002 · Journal of Medical Genetics
14. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity
    Shlomit Ezer, Muhannad Daana, Julien H. Park, Shira Yanovsky‐Dagan, Ulrika Nordström, Adily Basal, Simon Edvardson, Ann Saada, Markus Otto, Vardiella Meiner et al. · 2021 · Brain
15. Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population
    Keren Wang, Yuqin Ye, Zheli Xu, Xuan Zhang, Zhifu Hou, Youbin Cui, Yan Song · 2010 · Cancer Genetics and Cytogenetics
16. ATM variants and cancer risk in breast cancer patients from Southern Finland
    Johanna Tommiska, Laila Jansen, Outi Kilpivaara, Hege Edvardsen, Vessela Nedelcheva Kristensen, Anitta Tamminen, Kristiina Aittomäki, CARL P. BLOMQVIST, Anne‐Lise Børresen‐Dale, Heli A. Nevanlinna · 2006 · BMC Cancer
17. The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment
    Andrea Rabellino, Kum Kum Khanna · 2020 · Critical Reviews in Biochemistry and Molecular Biology
18. Low dose X-radiation adaptive response in spleen and prostate ofAtmknockout heterozygous mice
    Tanya K. Day, Antony M. Hooker, Guoxin Zeng, Pamela J. Sykes · 2007 · International Journal of Radiation Biology
19. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
    Hwei-Chung Wang, WEN-SHIN CHANG, Ru-Yin Tsai, Chia-Wen Tsai, Liang‐Chih Liu, Chen-Hsien Su, Hui Ni Cheng, Yung‐An Tsou, Shung-Shung Sun, Cheng‐Chieh Lin et al. · 2010 · PubMed
20. Effects of ataxia telangiectasia mutated (ATM) genotypes and smoking habits on lung cancer risk in Taiwan.
    Te‐Chun Hsia, Chia Wen Tsai, Shinn‐Jye Liang, Wen Shin Chang, Liang-Yi Lin, Wei-Chun Chen, Chih‐Yen Tu, Chang‐Hai Tsai, Da‐Tian Bau · 2013 · PubMed
21. Mutation screening of RAD51C in high-risk breast and ovarian cancer families
    Wenping Lü, Xianshu Wang, Hongsheng Lin, Noralane M. Lindor, Fergus J. Couch · 2012 · Familial Cancer
22. Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high‐performance liquid chromatography
    David P. Atencio, Christopher M. Iannuzzi, Sheryl Green, Richard G. Stock, Jonine L. Bernstein, Barry S. Rosenstein · 2001 · Environmental and Molecular Mutagenesis
23. Public Health Burden of Cancer in Ataxia-Telangiectasia Heterozygotes
    M Swift · 2001 · JNCI Journal of the National Cancer Institute
24. Atm Heterozygosity Cooperates with Loss of Brca1 to Increase the Severity of Mammary Gland Cancer and Reduce Ductal Branching
    Timothy J. Bowen, Hiroyuki Yakushiji, Cristina Montagna, Sonia Jain, Thomas Ried, Anthony J. Wynshaw-Boris · 2005 · Cancer Research
25. Cyclin D1 protein expression and gene polymorphism in colorectal cancer
    Judith McKay, Joy J. Douglas, Val G. Ross, Stephanie Curran, Graeme I. Murray, Jim Cassidy, on behalf of the Aberdeen Colorectal Initiative · 2000 · International Journal of Cancer
26. ATM germline mutations in Spanish early‐onset breast cancer patients negative for BRCA1/BRCA2 mutations
    Brunet, J, Gutiérrez‐Enríquez, S, Torres, A, Bérez, V, Sanjosé, S, Galceran, J, Izquierdo, À, Menéndez, JA, Gumà, J, Borràs, J · 2008 · Clinical Genetics
27. The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis
    Masoumeh Moslemi, Maryam Vafaei, Pouria Khani, Marzieh Soheili, Reza Nedaeinia, Mostafa Manian, Yousef Moradi, Ehsan Sohrabi · 2021 · Cancer Cell International
28. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases
    Jun-Xiao Zhang · 2015 · World Journal of Gastroenterology
29. Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene
    Alejandra Tavera-Tapia, Lucía Pérez‐Cabornero, J. A. Macías, Maria I. Ceballos, Giovanna Roncador, Miguel de la Hoya, A. Barroso, Vanesa Felipe-Ponce, Raquel Serrano‐Blanch, Carmen Hinojo et al. · 2016 · Breast Cancer Research and Treatment
30. Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer
    Parvin Mehdipour, Marzieh Mahdavi, Javad Mohammadi Asl, Morteza Atri · 2010 · Medical Oncology
31. ATM Gene Variants in Patients with Idiopathic Perifoveal Telangiectasia
    IRENE A. BARBAZETTO, Miia Room, Nicholas A. Yannuzzi, Gaetano R. Barile, Joanna E. Merriam, Anne M. C. Bardal, K. Bailey Freund, Lawrence A. Yannuzzi, Rando L. Allikmets · 2008 · Investigative Ophthalmology & Visual Science
32. Molecular variants of the ATM gene in Hodgkin's disease in children
    Ella Liberzon, Smadar Avigad, Isaac Yaniv, Batia Stark, Galia Avrahami, Yaacov Goshen, Rina Zaizov · 2004 · British Journal of Cancer
33. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia telangiectasia heterozygote cells
    Günter Speit, Kristina Trenz, Petra Schütz, Regina Bendix, Thilo Dörk · 2000 · Cytogenetic and Genome Research
34. The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?
    Florentine Hilbers, MPG Vreeswijk, Christie J. van Asperen, Peter Devilee · 2013 · Clinical Genetics
35. Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial Cells
    Stefano J. Mandriota, Raphaële Buser, Laurence Lesne, Christelle Stouder, Vincent Favaudon, Pierre Maechler, Frederique Sloan Bena, Virginie Clément, Curzio Rüegg, Roberto Montesano et al. · 2010 · Journal of Biological Chemistry
36. Histopathological features of breast cancer in carriers of ATM gene variants
    Rosemary L. Balleine, Rajmohan Murali, A. Michael Bilous, Gelareh Farshid, Paul Waring, Pamela J. Provan, Karen Byth, Heather Thorne, kConFab Investigators, J A Kirk · 2006 · Histopathology
37. A germline or de novo mutation in two families with Gaucher disease: implications for recessive disorders
    Hamid Saranjam, Sameer S. Chopra, Harvey L. Levy, Barbara K. Stubblefield, Emerson Maniwang, Ian Joseph Cohen, Hagit N. Baris, Ellen Sidransky, Nahid Tayebi · 2012 · European Journal of Human Genetics
38. Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms
    Borahm Kim, Hyeonah Lee, Ji Eun Jang, Soo‐Jeong Kim, Seung‐Tae Lee, June‐Won Cheong, Chuhl Joo Lyu, Yoo Hong Min, Jong Rak Choi · 2019 · PLoS ONE
39. A review of ground-based heavy ion radiobiology relevant to space radiation risk assessment: Cataracts and CNS effects
    Eleanor A. Blakely, Polly Y. Chang · 2007 · Advances in Space Research
40. Ataxia telangiectasia mutated‐dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor
    Hiroyuki Tamaichi, Masaki Sato, Andrew C.G. Porter, Toshiaki Shimizu, Shuki Mizutani, Masatoshi Takagi · 2012 · Cancer Science
41. Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer
    Fatima Aloraifi, Mirah Alshehhi, Trudi McDevitt, N Cody, Marie Meany, A. O’Doherty, Cecily Quinn, Andrew Green, Adrian P. Bracken, J. G. Geraghty · 2015 · European Journal of Surgical Oncology
42. Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations
    Alexandra O. Sokolova, Catherine Handy Marshall, Rebeca Lozano, Roman Gulati, Elisa Marie Ledet, Navonil De Sarkar, Petros D. Grivas, Celestia S. Higano, Bruce Montgomery, Peter S. Nelson et al. · 2021 · The Prostate
43. Ataxia-Telangiectasia genes and breast cancer risk in a French family study
    Nadine Andrieu, Eve Cavaciuti, Anthony Laugé, Katia Ossian, Nicolas Janin, Janet A. Hall, Dominique Stoppa‐Lyonnet · 2005 · Journal of Dairy Research
44. New mutations and protein variants of NBS1 are identified in cancer cell lines
    Alessandra Tessitore, Leda Assunta Biordi, Vincenzo Flati, Elena Toniato, Paolo Marchetti, Enrico Ricevuto, Corrado Ficorella, Luigi Scotto, Giuseppe Giannini, Luigi Frati et al. · 2002 · Genes Chromosomes and Cancer
45. Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families
    Geoffrey John Lindeman, Melody Hiew, Jane E. Visvader, Jennifer A. Leary, Michael J. Field, Clara Gaff, RJ McKinlay Gardner, Kevin Trainor, Glenice Cheetham, Graeme Suthers et al. · 2004 · Breast Cancer Research
46. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases
    Carmen Rodríguez, Hélène Vallès, Annick Causse, Vala Johannsdottir, Jean‐François Eliaou, Charles G. Theillet · 2001 · Genes Chromosomes and Cancer
47. Gene mutation as a target for early detection in cancer diagnosis
    Toshinari Minamoto, Ze’ev A. Ronai · 2001 · Critical Reviews in Oncology/Hematology
48. Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications
    Juan‐Manuel Hernandez‐Martinez, Rafael Rosell, Oscar G. Arrieta · 2023 · Critical Reviews in Oncology/Hematology
49. Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development
    Markéta Wayhelová, Vladimíra Vallová, Petr Brož, Aneta Mikulášová, Dominika Loubalova, Hana Filková, Jan Smetana, Klára Drábová, Renata Gaillyová, Petr Kuglík · 2021 · Journal of Human Genetics
50. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes
    Kristina Allen‐Brady, Nicola J. Camp · 2005 · BMC Cancer
51. A hypothesis about tumour development and the clinical features of hereditary breast cancers
    Hakan Lars Olsson · 2001 · European Journal of Cancer
52. Antaxia-telangiectasia mutated gene polymorphisms and susceptibility to chromosomal damage among polycyclic aromatic hydrocarbons exposed workers
    Yadong Wang, Huawei Duan, Yufei Dai, Ping Bin, Juan Cheng, Zufei Pan, Chuanfeng Huang, Shuguang Leng, Yuxin Zheng · 2009 · The Science of The Total Environment
53. A de novo or germline mutation in a family with Mucolipidosis III gamma: Implications for molecular diagnosis and genetic counseling
    Renata Voltolini Velho, Taciane Alegra, Fernanda Sperb, Nataniel Floriano Ludwig, Maria Luiza Saraiva Pereira, Úrsula da Silveira Matte, Ida Vanessa Döederlein Schwartz · 2014 · Molecular Genetics and Metabolism Reports
54. DNA damage and repair in individuals with ataxia-telangiectasia and their parents
    Roberta Passos Palazzo, Laura Bannach Jardim, Alexandre Bacellar, Fernanda Ramos de Oliveira, Flora Troina Maraslis, Carolina Hilgert Jacobsen Pereira, Juliana da Silva, Sharbel Weidner Maluf · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
55. Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study
    Catharina E. Jacobi, Nico J. D. Nagelkerke, Hans C. van Houwelingen, Geertruida H. de Bock · 2006 · Cancer Epidemiology Biomarkers & Prevention
56. Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers
    Anita Mangia, Patrizia Chiarappa, Stefania Tommasi, Annalisa Chiriatti, Stella Petroni, Francesco Schittulli, Angelo Paradiso · 2008 · Cancer Genetics and Cytogenetics
57. Association between Ataxia Telangiectasia Mutated Gene Polymorphisms and Childhood Leukemia in Taiwan
    Chung‐Hsing Wang, Kang‐Hsi Wu, Yung‐Li Yang, Ching‐Tien Peng, Fuu‐Jen Tsai, Dong‐Tsamn Lin, Chang‐Fang Chiu, Cheng‐Chieh Lin, Da‐Tian Bau · 2012 · The Chinese Journal of Physiology
58. The Founder Mutations in the BRCA1 , BRCA2 , and ATM Genes in Moroccan Jewish Women with Breast Cancer
    Yitshak Kreiss, Frida Barak, Ruth Gershoni Baruch, Ephrat Levy‐Lahad, Elon Pras, Eitan Friedman · 2000 · Genetic Testing
59. Screening breast cancer patients for Norwegian ATM mutations
    Kirsten Laake, P Vu, T I Andersen, Björn Erikstein, Rolf Kåresen, Per Eystein Lønning, Eva Skovlund, Anne‐Lise Børresen‐Dale · 2000 · British Journal of Cancer
60. ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen
    Rifat Ara Najnin, Md Rasel Al Mahmud, Md Maminur Rahman, Shunichi Takeda, Hiroyuki Sasanuma, Hisashi Tanaka, Yasuhiro Murakawa, Naoto Shimizu, Salma Akter, Masatoshi Takagi et al. · 2022 · Cell Reports
61. ATM polymorphisms IVS24-9delT, IVS38-8T>C, and 5557G>A in Mexican women with familial and/or early-onset breast cancer
    Fabiola Del Carmen Calderón-Zúñiga, Guadalupe Ocampo‐Gómez, Francisco Carlos López-Márquez, Rogelio Recio‐Vega, Luis Benjamín Serrano‐Gallardo, Pablo Ruíz-Flores · 2014 · Salud Pública de México
62. Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls
    Hong Ding, Chen Mao, Shui-Ming Li, Qu Liu, Lin Lin, Qing Chen · 2010 · Breast Cancer Research and Treatment
63. Multigene panel testing results in patients with multiple breast cancer primaries
    Jessica L. Corredor, Ashley Woodson, Angelica M. Gutierrez‐Barrera, Banu Arun · 2020 · The Breast Journal
64. Pharmacogenetics in the Management of Breast Cancer – Prospects for Individualised Treatment
    Fiona Helen Blackhall, Sacha Jon Howell, William G. Newman · 2006 · Familial Cancer
65. Mathematical Modeling for DNA Repair, Carcinogenesis and Cancer Detection
    Jonathan Tang, Walter Georgescu, Thomas Deschamps, Steven M. Yannone, Sylvain V. Costes · 2014 · Cancer metastasis
66. A systematic evaluation of the ataxia telangiectasia mutated gene does not show an association with non‐Hodgkin lymphoma
    Payal Sipahimalani, John Joseph Spinelli, Amy C. MacArthur, Agnes S. Lai, Stephen R. Leach, Rozmin Janoo-Gilani, Diana L. Palmquist, Joseph Michael Connors, Randy D. Gascoyne, Richard P. Gallagher et al. · 2007 · International Journal of Cancer
67. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells
    Geneviève Vaudan, Patrick Salmon, Laurence Mayor, László Vutskits, Christophe Cudré-Mauroux, Jesús V. Soriano, Roberto Montesano, Philippe Maillet, André‐Pascal Sappino · 2006 · Breast Cancer Research and Treatment
68. Re: Dominant Negative ATM Mutations in Breast Cancer Families
    H. Lei · 2002 · JNCI Journal of the National Cancer Institute
69. Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma
    Madeline B. Torres, Laurence P. Diggs, Jun Stephen Wei, Javed Iqbal Khan, Markku Miettinen, Grace‐Ann Fasaye, Andy Gillespie, Brigitte C. Widemann, Rosandra Natasha Kaplan, Jeremy L. Davis et al. · 2021 · Cancer Genetics
70. Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer
    D. Gareth Evans, George J. Burghel, Hélene Schlecht, Elaine F. Harkness, Ashu Gandhi, Sacha Jon Howell, Anthony Howell, Claire Forde, Fiona I. Lalloo, William G. Newman et al. · 2023 · Journal of Medical Genetics
71. Age at Onset of Bilateral Breast Cancer, the Presence of Hereditary BRCA1, BRCA2, CHEK2 Gene Mutations and Positive Family History of Cancer
    Elżbieta Skasko, Anna Kluska, Anna Niwińska, E Kwiatkowska, Aneta Bałabas, Magdalena Piątkowska, Michalina Dąbrowska, Dorota Nowakowska, Tadeusz Pieńkowski · 2009 · Oncology Research and Treatment
72. Contemporary Cancer Research
    Wayne W. Grody, James T. Wu, Raymond B. Nagle, David T. Curiel, Joanne T. Douglas, Jac A. Nickoloff, Merl F. Hoekstra, Jac A. Nickoloff · 2005
73. Cancer risk‐reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast)
    Vandré Cabral Gomes Carneiro, Ana Carolina Leite Vieira Costa Gifoni, Benedito Mauro Rossi, Carlos Eduardo Mattos da Cunha Andrade, Fernanda Teresa de Lima, Henrique de Campos Reis Galvão, José Cláudio Casali da Rocha, Leonardo Silveira da Silva Barreto, Patrícia Ashton‐Prolla, Rodrigo Santa Cruz Guindalini et al. · 2022 · Journal of Surgical Oncology
74. Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity
    Rong Bu, Abdul K. Siraj, Maha M. Al-Rasheed, Kaleem Iqbal, Saud Azam, Zeeshan Qadri, Wael Haqawi, Asma M. Tulbah, Fouad Al‐Dayel, Osama Almalik et al. · 2023 · Scientific Reports
75. Dissecting Intra-Tumor Heterogeneity by the Analysis of Copy Number Variations in Single Cells: The Neuroblastoma Case Study
    Federica Cariati, Francesca Borrillo, Varun Shankar, Marcella Nunziato, Valeria D’Argenio, Rossella Tomaiuolo · 2019 · International Journal of Molecular Sciences
76. Molecular basis of inherited predispositions for tumors.
    Jan Lubiński, Bohdan Górski, Grzegorz Kurzawski, Anna Jakubowska, Cezary Cybulski, Janina Suchy, Tadeusz Dębniak, Ewa A. Grabowska, Marcin Radosław Lener, Katarzyna Nej‐Wołosiak · 2002 · Acta Biochimica Polonica
77. Diagnosis of Ataxia-Telangiectasia
    Midori Mitsui, Shareef Nahas, Helen H. Chun, Richard A. Gatti · 2004 · Humana Press eBooks
78. Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations
    Maria G. Fencer, Kelly Krupa, Gabrielle Bleich, Sherry Grumet, Firas G. Eladoumikdachi, Shicha Kumar, Maria J. Kowzun, Lindsay B. Potdevin · 2023 · Clinical Breast Cancer
79. Population-based study of recurrent DNA damage response gene variants in breast cancer cases
    Anna Tervasmäki, Timo A. Kumpula, Mervi Grip, Susanna Koivuluoma, Meeri Seuranen, Robert Winqvist, Tuomo Mantere, Katri Pylkäs · 2025 · Breast Cancer Research and Treatment
80. Encyclopaedia of tumour-associated familial disorders. Part I: from AIMAH to CHIME syndrome
    Rolf H. Sijmons · 2008 · Hereditary Cancer in Clinical Practice
81. Breast Cancer Genetics
    Henry T. Lynch, Joseph N. Marcus, J.ane. Lynch, Carrie Snyder, Wendy S. Rubinstein · 2009 · Elsevier eBooks
82. Precision therapy for cancer prevention by targeting carcinogenesis
    Guoguo Jin, Kangdong Liu, Zhiping Guo, Zigang Dong · 2024 · Molecular Carcinogenesis
83. The Genetic Basis of Cancer
    Akseli Hemminki, Kari Hemminki · 2007 · Humana Press eBooks
84. ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells
    Peng Xu, Yuanyuan Sun, Yuanming Song, Jiao Jiao, Beibei Shen, Weidong Li, Cheng‐Ying Jiang, Yaqing Li, Xinmin Zhang, Jinpu Yu et al. · 2020 · Medical Molecular Morphology
85. Role if ATM IVS10-6T→G Polymorphism in Breast Cancer; A Case-control Study in High-risk Kashmiri Population
    Nidda Syeed Firdous Hussain · 2014 · Journal of Carcinogenesis & Mutagenesis
86. Cáncer de mama y mutación del gen ataxia telangiectasia: reporte de caso
    Clínica Medellín, Grupo de Investigación en Cáncer IDC. Medellín, Colombia, Oscar Alejandro Bonilla Sepúlveda · 2023 · Horizonte Médico (Lima)
87. Novel Hypothesis on Telomere Length: Heterogenic Targets as Genomic/Somatic Diverse Value in Breast Cancer and Brain Tumor
    Parvin Mehdipour · 2012 · Springer eBooks
88. Molecular cytogenetic parameters in fibroblasts of ataxia telangiectasia carrier
    Aliza Amiel, Gadi Drori, Galina Weinstein, Moshe D Fejgin · 2004 · Cancer Genetics and Cytogenetics
89. Is Ataxia Telangiectasia a Result of Impaired Coordination between DNA Repair and Cell Cycle Checkpoint Regulators?
    Adayabalam S. Balajee, Charles R. Geard · 2006 · Springer eBooks
90. Stereotactic Radiosurgery for Brain Metastases in Patients With a Heterozygous Germline Ataxia Telangiectasia Mutated Gene
    Jennifer C. Hall, Steven Daniel Chang, Melanie Hayden Gephart, Erqi Liu Pollom, Santino S. Butler · 2023 · Cureus
91. Whole genome joint analysis reveals ATM:C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer
    Mario Ćuk, Busra Unal, Connor P. Hayes, McKenzie Walker, Anđela Bevanda, Viktorija Antolović, Arezou A. Ghazani · 2024 · Cancer Genetics
92. Germline variants in the ATM gene and breast cancer susceptibility in Moroccan women: A meta-analysis
    Chaymaa Marouf, Omar Hajji, Amal Tazzite, H. Jouhadi, Abdellatif Benider, Sellama Nadifi · 2017 · Egyptian Journal of Medical Human Genetics
93. Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure
    Deepa Sridharan, Shiena Enerio, Chris Wang, Mark A. LaBarge, Martha R. Stampfer, Janice M. Pluth · 2018 · Life Sciences in Space Research
94. ATM (ataxia telangiectasia mutated)
    N Uhrhammer, JO Bay, RA Gatti · 2011 · Atlas of Genetics and Cytogenetics in Oncology and Haematology
95. The DNA repair kinase ATM regulates CD13 expression and cell migration
    Louise K. Stevenson, Amy J. Page, Matthew Dowson, Sameh K. ElBadry, Francis Mprah Barnieh, Robert A. Falconer, Sherif F. El‐Khamisy · 2024 · Frontiers in Cell and Developmental Biology
96. Classification of Gene Variants in a Danish Population with Suspected Predisposition to Hereditary Breast and/or Ovarian Cancer
    Anne K. Munch, Elisabeth Simone Feldner, Caroline Hey Bækgaard, Mie B. Larsen, Naja Slemming-Adamsen, Desirée Sofie Boonen, Nanna Bæk Møller, Inge Søkilde Pedersen, Thomas van Overeem Hansen, Thorkild Terkelsen et al. · 2025 · Cancers
97. Germline alterations in patients with lung cancer
    Ramaswamy Govindan, Katie Navo, M. Huang, Jia Liu, Calvin Y. Chao, Xiaoyu Zong, S. Sankararaman, K. Bolton, Y. Cao · 2025 · Annals of Oncology
98. A historical perspective on familial cancer: results and vision of the Polyposis Center Project
    Joji Utsunomiya, Takeo Iwama∥, Michiko Miyaki, Kazuo Tamura, Masami Arai · 2004 · International Journal of Clinical Oncology
99. DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer
    Minna Allinen · 2002
100. A Case-Control Study of ATM and Susceptibility to Squamous Cell Carcinoma of the Head and Neck
     Sarah Elizabeth Grams · 2007 · D-Scholarship@Pitt (University of Pittsburgh)